125 related articles for article (PubMed ID: 16883326)
1. Safety first: messages from Digestive Disease Week 2006.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):415. PubMed ID: 16883326
[No Abstract] [Full Text] [Related]
2. [Octreotide (Famsynthesis): new possibilities in gastroenterology].
Velichko MA; Vreshch VD
Voen Med Zh; 2001 May; 322(5):44-5. PubMed ID: 11550331
[No Abstract] [Full Text] [Related]
3. Digestive Disease Week 2009. Turning science into medicine: Part 2.
Glah DR
IDrugs; 2009 Aug; 12(8):471-3. PubMed ID: 19629876
[No Abstract] [Full Text] [Related]
4. [NSAIDs or coxibs: benefits and gastrointestinal vs. cardiovascular effects].
Ballesteros Amozurrutia MA
Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():22-5. PubMed ID: 17037763
[No Abstract] [Full Text] [Related]
5. [New aspects in the use of pirenzepine for the treatment of digestive organ diseases].
Degtiareva II; Khatib Z; Palladina OL; Lodianaia EV; Kharchenko NV; Chernenko VV; Piletskiĭ AM; Nevstruev VP; Chervak IN
Lik Sprava; 1997; (4):83-6. PubMed ID: 9471384
[No Abstract] [Full Text] [Related]
6. [Drug therapy of major gastroenterologic diseases].
Ryss ES; Fishzon-Ryss IuI
Sov Med; 1989; (11):37-41. PubMed ID: 2626707
[No Abstract] [Full Text] [Related]
7. Digestive Disease Week 2005. Drug highlights I.
De La Rue SA
IDrugs; 2005 Jul; 8(7):537-8. PubMed ID: 15973557
[No Abstract] [Full Text] [Related]
8. [Clinical value of the correction of disorders of intestinal microcenosis in patients with acid-dependent diseases of the digestive apparatus].
Tkachenko EI; Uspenskiĭ IuP; Avalueva EB; Zakharchenko MM; Baryshnikova NV
Eksp Klin Gastroenterol; 2004; (6):52-6. PubMed ID: 16259442
[No Abstract] [Full Text] [Related]
9. [Prokinetic medication in gastroenterology].
Lachter J; Eidelman S
Harefuah; 1998 Apr; 134(7):553-7. PubMed ID: 10909602
[No Abstract] [Full Text] [Related]
10. [Pharmacoeconomics: the basic concepts and their application to digestive medicine].
Díaz de Rojas F
Gastroenterol Hepatol; 1997 Feb; 20(2):68-77. PubMed ID: 9072207
[No Abstract] [Full Text] [Related]
11. [Sense and nonsense in therapy with "digestive preparations"].
Fleig WE
ZFA (Stuttgart); 1982 Nov; 58(31):1695-701. PubMed ID: 6897473
[No Abstract] [Full Text] [Related]
12. [Evaluation of the clinical effectiveness of tiropramide in various functional syndromes of the digestive track].
Cataldo MG; Rotolo G; Salvia M; Turiano S; Caudullo V; Bongiorno A
Minerva Dietol Gastroenterol; 1987; 33(1):67-70. PubMed ID: 3295595
[No Abstract] [Full Text] [Related]
13. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract.
Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K
J Gastroenterol Hepatol; 2009 Apr; 24(4):537-46. PubMed ID: 19220673
[TBL] [Abstract][Full Text] [Related]
14. Coxibs and heart disease: what we have learned and what else we need to know.
Zarraga IG; Schwarz ER
J Am Coll Cardiol; 2007 Jan; 49(1):1-14. PubMed ID: 17207715
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
Hennekens CH; Borzak S
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
19. Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.
Schiller LR; Johnson DA
Am J Gastroenterol; 2008 Apr; 103(4):815-9. PubMed ID: 18397418
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
Lange H; Eberhart L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
